Abstract
Protein misfolding and aggregation into nano-scale ordered amyloid fibrils is one of the most exciting field of Biochemistry. The correct folding is essential for function of proteins and thus, existence of living systems. An effective protein quality control in living system recognizes and degrades misfolded protein quickly and prevents aggregation. Dysfunction or impaired function of this quality control system may result in deposition of protein aggregates. A number of diseases have been linked to deposition of insoluble amyloid aggregates in the brain or other organs. Recently, researchers have reported nano-based therapeutic options and early detection techniques for amyloid diseases. Moreover, thermodynamics of misfolding and aggregation has provided important clue for drug development. Researchers across the globe are working on the development of therapeutic strategies to combat protein aggregation diseases. In the current review, we aim to bring together recent developments about protein misfolding, aggregation and therapeutics against protein misfolding/ aggregation diseases.
Keywords: Protein folding, diseases, nano-fibrils
Current Proteomics
Title: Protein Nano-Fibrilar Structure and Associated Diseases
Volume: 7 Issue: 2
Author(s): Nandini Sarkar and Vikash Kumar Dubey
Affiliation:
Keywords: Protein folding, diseases, nano-fibrils
Abstract: Protein misfolding and aggregation into nano-scale ordered amyloid fibrils is one of the most exciting field of Biochemistry. The correct folding is essential for function of proteins and thus, existence of living systems. An effective protein quality control in living system recognizes and degrades misfolded protein quickly and prevents aggregation. Dysfunction or impaired function of this quality control system may result in deposition of protein aggregates. A number of diseases have been linked to deposition of insoluble amyloid aggregates in the brain or other organs. Recently, researchers have reported nano-based therapeutic options and early detection techniques for amyloid diseases. Moreover, thermodynamics of misfolding and aggregation has provided important clue for drug development. Researchers across the globe are working on the development of therapeutic strategies to combat protein aggregation diseases. In the current review, we aim to bring together recent developments about protein misfolding, aggregation and therapeutics against protein misfolding/ aggregation diseases.
Export Options
About this article
Cite this article as:
Sarkar Nandini and Kumar Dubey Vikash, Protein Nano-Fibrilar Structure and Associated Diseases, Current Proteomics 2010; 7 (2) . https://dx.doi.org/10.2174/157016410791330516
DOI https://dx.doi.org/10.2174/157016410791330516 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
Peptides: State-of-Art and Commercialisation Hurdles
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inflammatory and Cell Death Pathways in Brain and Peripheral Blood in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Protein Conformational Diseases: From Mechanisms to Drug Designs
Current Drug Discovery Technologies Ruthenium as an Effective Nitric Oxide Scavenger
Current Topics in Medicinal Chemistry Hyperhomocysteinemia, Pteridines and Oxidative Stress
Current Drug Metabolism Molecular Imaging of Apoptosis In Vivo with Scintigraphic and Optical Biomarkers – A Status Report
Anti-Cancer Agents in Medicinal Chemistry Predementia and Dementia Syndromes: Possible Role of Lipoprotein Metabolism
Vascular Disease Prevention (Discontinued) Cytokines in Dementias
Current Drug Targets - Inflammation & Allergy Consensus Guideline Based Therapeutic Drug Monitoring (TDM) in Psychiatry and Neurology
Current Drug Delivery Detection and Transport Mechanisms of Circulating microRNAs in Neurological, Cardiac and Kidney Diseases
Current Medicinal Chemistry Laminin and its Related Peptides for the Treatment of Alzheimers Disease
Current Medicinal Chemistry - Central Nervous System Agents Nutraceuticals, Nutritional Therapy, Phytonutrients, and Phytotherapy for Improvement of Human Health: A Perspective on Plant Biotechnology Application
Recent Patents on Biotechnology Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer’s Disease
Current Neurovascular Research Driving Cellular Plasticity and Survival Through the Signal Transduction Pathways of Metabotropic Glutamate Receptors
Current Neurovascular Research Antimetastatic Potential of Quercetin Analogues with Improved Pharmacokinetic Profile: A Pharmacoinformatic Preliminary Study
Anti-Cancer Agents in Medicinal Chemistry Dementia and the Default Mode
Current Alzheimer Research Going up in Smoke? A Review of nAChRs-based Treatment Strategies for Improving Cognition in Schizophrenia
Current Pharmaceutical Design Neurogenesis in Alzheimers Disease: A Realistic Alternative to Neuronal Degeneration?
Current Signal Transduction Therapy Chronic Immune Stimulation Correlates with Reduced Phenylalanine Turnover
Current Drug Metabolism Mechanisms of Neuronal Damage and Neuroprotection Underlying Ischemia/Reperfusion Injury after Physical Exercise
Current Drug Targets Cellular Protection and Therapeutic Potential of Tocotrienols
Current Pharmaceutical Design